Gentaur Epcoritamab – Anti-CD3E / CD20 (MS4A1) Bispecific

Gentaur Epcoritamab – Anti-CD3E / CD20 (MS4A1) Bispecific

Bridges T-cells to B-cells by binding CD3E and CD20, driving targeted B-cell depletion. Ideal for lymphoma and immunotherapy models.

1,234,567.00 € 1234567.0 EUR 1,234,567.00 €

1,234,567.00 €

This combination does not exist.

Terms and Conditions
30-day money-back guarantee
Shipping: 2-3 Business Days